Form4insider filings, from the source

Company · CIK 0001818382 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Humacyte, Inc. · HUMA

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $30k · 3sales $0 · 0net $30k
$10k$10k$100k$100k$1M$1MbuyssalesJun 28Jul 13Jul 28Aug 13Aug 28Sep 13Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 14, 2026 PForm 4 →Sep 15, 4:05 pm EDTKeith Anthony JonesDirector10,000$0.562$5,62050,000+25.0%
Aug 20, 2026 PForm 4 →Aug 21, 4:05 pm EDTKeith Anthony JonesDirector10,000$0.693$6,93040,000+33.3%
Aug 17, 2026 PForm 4 →Aug 19, 4:00 pm EDTKeith Anthony JonesDirector30,000$0.594$17,82030,000—

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.